117 related articles for article (PubMed ID: 1640779)
1. Double-blind evaluation of BACTEC and Buddemeyer-type radiorespirometric assays for in vitro screening of antileprosy agents.
Franzblau SG; Biswas AN; Jenner P; Colston MJ
Lepr Rev; 1992 Jun; 63(2):125-33. PubMed ID: 1640779
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of palmitic acid by Mycobacterium leprae in an axenic medium.
Franzblau SG
J Clin Microbiol; 1988 Jan; 26(1):18-21. PubMed ID: 3125213
[TBL] [Abstract][Full Text] [Related]
3. Drug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system.
Franzblau SG
Antimicrob Agents Chemother; 1989 Dec; 33(12):2115-7. PubMed ID: 2694952
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of phenolic glycolipid-I synthesis in extracellular Mycobacterium leprae as an indicator of antimicrobial activity.
Harris EB; Franzblau SG; Hastings RC
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):588-91. PubMed ID: 3065422
[TBL] [Abstract][Full Text] [Related]
5. Rapid in vitro metabolic screen for antileprosy compounds.
Franzblau SG; Hastings RC
Antimicrob Agents Chemother; 1987 May; 31(5):780-3. PubMed ID: 3300539
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activities of 20 fluoroquinolones against Mycobacterium leprae.
Franzblau SG; White KE
Antimicrob Agents Chemother; 1990 Feb; 34(2):229-31. PubMed ID: 2183714
[TBL] [Abstract][Full Text] [Related]
7. Limited in vitro multiplication of Mycobacterium leprae: application to screening potential antileprosy compounds.
Dhople AM; Green KJ
Lepr Rev; 1986; 57 Suppl 3():149-62. PubMed ID: 3553808
[No Abstract] [Full Text] [Related]
8. Application of ATP assay for in vitro drug screening testing against human derived M. leprae.
Katoch VM; Katoch K; Shivannavar CT; Sharma VD; Patil MA; Bharadwaj VP
Indian J Lepr; 1989 Jul; 61(3):333-44. PubMed ID: 2671179
[TBL] [Abstract][Full Text] [Related]
9. Newer drugs in leprosy.
Grosset JH
Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S14-8. PubMed ID: 11757174
[TBL] [Abstract][Full Text] [Related]
10. Search for newer antileprosy drugs.
Dhople AM
Indian J Lepr; 2000; 72(1):5-20. PubMed ID: 10935183
[TBL] [Abstract][Full Text] [Related]
11. Titration of numbers of human-derived Mycobacterium leprae required to progressively oxidize 14C-palmitic acid and release 14CO2.
Shannon EJ; Frommel D; Guebre-Xabier M; Haile-Mariam HS
Lepr Rev; 1994 Jun; 65(2):100-5. PubMed ID: 7968182
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antileprosy activity of some dialkyldithiocarbamates.
Makarov V; Riabova OB; Yuschenko A; Urlyapova N; Daudova A; Zipfel PF; Möllmann U
J Antimicrob Chemother; 2006 Jun; 57(6):1134-8. PubMed ID: 16595643
[TBL] [Abstract][Full Text] [Related]
13. [Drug resistance of Mycobacterium leprae].
Pattyn SR
Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
[No Abstract] [Full Text] [Related]
14. Study of antileprosy activities of some dialkyldithiocarbamate derivatives.
Urlyapova NG; Yushchenko AA; Daudova AD; Makarov VA
Bull Exp Biol Med; 2007 Mar; 143(3):356-8. PubMed ID: 18225763
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of antimicrobial agents on Mycobacterium leprae in mouse peritoneal macrophages.
Ramasesh N; Krahenbuhl JL; Hastings RC
Antimicrob Agents Chemother; 1989 May; 33(5):657-62. PubMed ID: 2665640
[TBL] [Abstract][Full Text] [Related]
16. Measurement of hypoxanthine incorporation in purified suspensions of Mycobacterium leprae: a suitable method to screen for anti-leprosy agents in vitro.
Wheeler PR
J Med Microbiol; 1988 Mar; 25(3):167-74. PubMed ID: 3279214
[TBL] [Abstract][Full Text] [Related]
17. In vitro resistance test of human leprosy bacilli to anti-leprous drugs.
Ishihara S; Hagiwara S; Fujuda T
Microbios; 1977; 19(76):117-23. PubMed ID: 366337
[TBL] [Abstract][Full Text] [Related]
18. Mouse foot pad technique for evaluation of drug resistance of M. leprae and other laboratory techniques to be used in leprosy control programmes.
Pattyn SR
Acta Leprol; 1983; 1(1):29-32. PubMed ID: 6401137
[TBL] [Abstract][Full Text] [Related]
19. [Basic evaluation for new antimicrobial susceptibility testing of Mycobacterium leprae by bioluminescence assay (ATP method)].
Yamazaki T; Gidoh M; Matsuoka M
Nihon Hansenbyo Gakkai Zasshi; 2006 Sep; 75(3):227-37. PubMed ID: 17037377
[TBL] [Abstract][Full Text] [Related]
20. Radiolabeling of Mycobacterium leprae lipids within schwannoma cells, a potential drug screening system.
Mistry Y; Antia NH; Mukherjee R
Antimicrob Agents Chemother; 1991 Jul; 35(7):1444-7. PubMed ID: 1929306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
